These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17670852

  • 1. Successful treatment of refractory neuroSjogren with Rituximab.
    Yamout B, El-Hajj T, Barada W, Uthman I.
    Lupus; 2007; 16(7):521-3. PubMed ID: 17670852
    [Abstract] [Full Text] [Related]

  • 2. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [Abstract] [Full Text] [Related]

  • 3. Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.
    Somer BG, Tsai DE, Downs L, Weinstein B, Schuster SJ, American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines.
    Arthritis Rheum; 2003 Jun 15; 49(3):394-8. PubMed ID: 12794796
    [No Abstract] [Full Text] [Related]

  • 4. Prolonged remission of a demyelinating neuropathy in a patient with lymphoma and Sjögren's syndrome after Rituximab therapy.
    Botez SA, Herrmann DN.
    J Clin Neuromuscul Dis; 2010 Mar 15; 11(3):127-31. PubMed ID: 20215986
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K, Lamprecht P, Nölle B, Ai M, Gross WL.
    Ann Rheum Dis; 2005 Jul 15; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract] [Full Text] [Related]

  • 6. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.
    Pijpe J, van Imhoff GW, Vissink A, van der Wal JE, Kluin PM, Spijkervet FK, Kallenberg CG, Bootsma H.
    Ann Rheum Dis; 2005 Jun 15; 64(6):958-60. PubMed ID: 15576414
    [Abstract] [Full Text] [Related]

  • 7. Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
    De Vita S, Quartuccio L, Salvin S, Picco L, Scott CA, Rupolo M, Fabris M.
    Clin Exp Rheumatol; 2014 Jun 15; 32(4):490-4. PubMed ID: 24802131
    [Abstract] [Full Text] [Related]

  • 8. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
    Nikiphorou E, Hall FC.
    Rheumatology (Oxford); 2014 Oct 15; 53(10):1906-7. PubMed ID: 24729401
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement].
    Yamanishi Y, Taooka Y, Mukuzono H, Aoi K, Ishibe Y, Yamana S.
    Ryumachi; 1994 Jun 15; 34(3):633-8. PubMed ID: 8052929
    [Abstract] [Full Text] [Related]

  • 11. [A case of Sjögren's syndrome with subacute transverse myelitis as the initial manifestation].
    Arai C, Furutani R, Ushiyama M.
    Rinsho Shinkeigaku; 2002 Jul 15; 42(7):613-8. PubMed ID: 12661106
    [Abstract] [Full Text] [Related]

  • 12. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.
    Mekinian A, Ravaud P, Larroche C, Hachulla E, Gombert B, Blanchard-Delaunay C, Cantagrel A, Fain O, Sibilia J, Gottenberg JE, Mariette X, Club Rhumatismes et Inflammation.
    Clin Exp Rheumatol; 2012 Jul 15; 30(2):208-12. PubMed ID: 22341206
    [Abstract] [Full Text] [Related]

  • 13. [A case of brachial amyotrophic diplegia accompanied with Sjögren's syndrome presenting good response to immunotherapies in the early course of the disease].
    Takakura Y, Murai H, Furuya H, Ochi H, Kira J.
    Rinsho Shinkeigaku; 2005 May 15; 45(5):346-50. PubMed ID: 15960170
    [Abstract] [Full Text] [Related]

  • 14. [Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].
    Vasil'ev VI, Kokosadze NV, Logvinenko OA, Nikitin EA, Mitrikov BV, Rodionova EB, Varlamova EIu.
    Ter Arkh; 2008 May 15; 80(5):76-9. PubMed ID: 18590121
    [No Abstract] [Full Text] [Related]

  • 15. Acute sensory neuronopathy as the presenting symptom of Sjögren's syndrome.
    Souayah N, Chong PS, Cros D.
    J Clin Neurosci; 2006 Oct 15; 13(8):862-5. PubMed ID: 16935510
    [Abstract] [Full Text] [Related]

  • 16. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, Hutin P, Renaudineau Y, Dueymes M, Loisel S, Berthou C, Saraux A, Youinou P.
    Arthritis Rheum; 2007 May 15; 56(5):1464-77. PubMed ID: 17469105
    [Abstract] [Full Text] [Related]

  • 17. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
    Rodella E, Pacquola E, Bianchini E, Ramazzina E, Paolini R.
    Blood Coagul Fibrinolysis; 2008 Jun 15; 19(4):315-8. PubMed ID: 18469554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.